Prognostic Implications Over Time of Platelet FcɣRIIa Expression in Patients With Myocardial Infarction: A Secondary Analysis
The pFCG test is a powerful prognostic marker of ischemic risk during the first 6 months after MI. The prognostic information provided by the pFCG test should be useful to clinicians as they balance risk of ischemic events with that of bleeding to define a treatment strategy.
Authors
- Homam Ibrahim (ORCID: https://orcid.org/0000-0002-6728-3143)
- Mark B. Effron (ORCID: https://orcid.org/0000-0003-4050-5030)
- Dominick J. Angiolillo (ORCID: https://orcid.org/0000-0001-8451-2131)
- Patrick Hohl
- Alexander C. Fanaroff (ORCID: https://orcid.org/0000-0002-9060-5307)
- Brett Wanamaker (ORCID: https://orcid.org/0000-0002-4072-8704)
- Peter M. DiBattiste
- David J. Schneider (ORCID: https://orcid.org/0000-0002-2751-6870)
- Sean McMahon (ORCID: https://orcid.org/0000-0002-6944-8140)
Institutions
- University of Vermont (US)
- Hartford Hospital (US)
- Maine Medical Center (US)
- Ochsner Health System (US)
- Baylor University (US)
- University of Michigan (US)
- Ochsner Medical Center (US)
- Jacksonville University (US)
- Maine Medical Center (US)
- Adventist HealthCare Rehabilitation (US)
- University of Florida Health Science Center (US)
- University of Pennsylvania (US)
- Florida College (US)
Publication Details
- Journal
- The Journal of invasive cardiology/The journal of invasive cardiology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.25270/jic/25.00102
- Primary Topic
- Cardiac electrophysiology and arrhythmias
- Type
- article
- Field-Weighted Citation Impact
- 0.00